| Dr Jeremy J Gitomer, MD | |
|
4015 Lake Otis Pkwy, Suite 101, Anchorage, AK 99508-5211 | |
| (907) 375-5200 | |
| (907) 375-5201 |
| Full Name | Dr Jeremy J Gitomer |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 32 Years |
| Location | 4015 Lake Otis Pkwy, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073509063 | NPI | - | NPPES |
| 1017876 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 5028 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Liberty Dialysis - Alaska Llc | Anchorage, AK | Dialysis facility |
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Alaska Regional Hospital | Anchorage, AK | Hospital |
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kidney And Hypertension Clinic Of Alaska Inc | 0840299186 | 9 |
News Archive
Mammography is the current state-of-the-art method for detecting and diagnosing breast cancer. However, even a mammogram doesn't detect certain subtle breast cancers, especially those in younger women who typically have denser breast tissue.
Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary, Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, has signed a collaboration agreement for PHOTOFRIN® with Orphan Canada, a Toronto-based specialty pharmaceutical company that in‐licenses therapies for rare disorders and specialty medicines within Canada.
One of the strongest known risk factors for spontaneous or unexpected preterm birth - any birth that occurs before the 37th week of pregnancy, most often without a known cause - is already having had one. For women in this group who would like to avoid this scenario in their second pregnancy, focusing on weight gain and dietary changes may not be the best strategy. A new study reported at the Society for Maternal-Fetal Medicine's annual meeting found no connection between weight gain and the risk of repeat preterm birth.
Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.
› Verified 2 days ago
| Entity Name | Dialysis Associates Of Alaska, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912013160 PECOS PAC ID: 1456345123 Enrollment ID: O20040414000683 |
News Archive
Mammography is the current state-of-the-art method for detecting and diagnosing breast cancer. However, even a mammogram doesn't detect certain subtle breast cancers, especially those in younger women who typically have denser breast tissue.
Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary, Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, has signed a collaboration agreement for PHOTOFRIN® with Orphan Canada, a Toronto-based specialty pharmaceutical company that in‐licenses therapies for rare disorders and specialty medicines within Canada.
One of the strongest known risk factors for spontaneous or unexpected preterm birth - any birth that occurs before the 37th week of pregnancy, most often without a known cause - is already having had one. For women in this group who would like to avoid this scenario in their second pregnancy, focusing on weight gain and dietary changes may not be the best strategy. A new study reported at the Society for Maternal-Fetal Medicine's annual meeting found no connection between weight gain and the risk of repeat preterm birth.
Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.
› Verified 2 days ago
| Entity Name | Kidney And Hypertension Clinic Of Alaska Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932282381 PECOS PAC ID: 0840299186 Enrollment ID: O20061213000556 |
News Archive
Mammography is the current state-of-the-art method for detecting and diagnosing breast cancer. However, even a mammogram doesn't detect certain subtle breast cancers, especially those in younger women who typically have denser breast tissue.
Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary, Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, has signed a collaboration agreement for PHOTOFRIN® with Orphan Canada, a Toronto-based specialty pharmaceutical company that in‐licenses therapies for rare disorders and specialty medicines within Canada.
One of the strongest known risk factors for spontaneous or unexpected preterm birth - any birth that occurs before the 37th week of pregnancy, most often without a known cause - is already having had one. For women in this group who would like to avoid this scenario in their second pregnancy, focusing on weight gain and dietary changes may not be the best strategy. A new study reported at the Society for Maternal-Fetal Medicine's annual meeting found no connection between weight gain and the risk of repeat preterm birth.
Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeremy J Gitomer, MD Po Box 196800, Anchorage, AK 99519-6800 Ph: (907) 375-5200 | Dr Jeremy J Gitomer, MD 4015 Lake Otis Pkwy, Suite 101, Anchorage, AK 99508-5211 Ph: (907) 375-5200 |
News Archive
Mammography is the current state-of-the-art method for detecting and diagnosing breast cancer. However, even a mammogram doesn't detect certain subtle breast cancers, especially those in younger women who typically have denser breast tissue.
Concordia Healthcare Corp., a diverse healthcare company focused on legacy pharmaceutical products, orphan drugs, and medical devices for the diabetic population, today announced that its subsidiary, Pinnacle Biologics, Inc., a biopharmaceutical research and development company specializing in rare diseases, has signed a collaboration agreement for PHOTOFRIN® with Orphan Canada, a Toronto-based specialty pharmaceutical company that in‐licenses therapies for rare disorders and specialty medicines within Canada.
One of the strongest known risk factors for spontaneous or unexpected preterm birth - any birth that occurs before the 37th week of pregnancy, most often without a known cause - is already having had one. For women in this group who would like to avoid this scenario in their second pregnancy, focusing on weight gain and dietary changes may not be the best strategy. A new study reported at the Society for Maternal-Fetal Medicine's annual meeting found no connection between weight gain and the risk of repeat preterm birth.
Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.
Takeda Pharmaceuticals U.S.A., Inc. and Orexigen® Therapeutics, Inc. jointly announced today that the U.S. Food and Drug Administration has approved Contrave® extended-release tablets as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index of 30 kg/m2 or greater (obese), or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.
› Verified 2 days ago
Andrea Caballero, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3220 Providence Dr Ste E3-080, Anchorage, AK 99508 Phone: 907-375-8785 Fax: 907-375-8788 | |
Daryl M. Mcclendon, M.D., P.C. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper Street, Suite U466, Anchorage, AK 99508 Phone: 907-569-1333 Fax: 907-569-1433 | |
Dr. Loretta Leih-sheng Lee, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4001 Dale St, Suite 210, Anchorage, AK 99508 Phone: 907-929-5880 Fax: 907-929-5882 | |
Dr. Richard Merle Farleigh, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 4120 Laurel St, Suite 202, Anchorage, AK 99508 Phone: 907-561-4293 | |
Alexis Leandro Delgado, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4300 B St, Suite 200, Anchorage, AK 99503 Phone: 907-375-3355 Fax: 907-375-3351 | |
Geronimo Sahagun, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2841 Debarr Road, Suite 50, Anchorage, AK 99508 Phone: 907-276-2811 Fax: 907-276-2810 | |
Dr. Tram Phuong Chu, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3200 Providence Dr, Suite B111, Anchorage, AK 99508 Phone: 907-212-7890 Fax: 907-212-2374 |